Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
复制标题
DOI:
10.1016/j.antiviral.2017.08.007
复制
发表时间:
2017-10
影响因子:
7.6
通讯作者:
Kobayashi T
中科院分区:
文献类型:
--
作者:
Kamiyama N;Soma R;Hidano S;Watanabe K;Umekita H;Fukuda C;Noguchi K;Gendo Y;Ozaki T;Sonoda A;Sachi N;Runtuwene LR;Miura Y;Matsubara E;Tajima S;Takasaki T;Eshita Y;Kobayashi T
Zika fever, a mosquito-borne infectious disease caused by Zika virus (ZIKV), is an epidemic disease for which no effective therapy has been established. The recent outbreaks of ZIKV in Brazil and French Polynesia have been linked to a considerable increase in the incidence of fetal microcephaly and other diseases such as Guillain-Barre syndrome. Because there is currently no specific therapy or vaccine, the early exploitation of a method to prevent expansion of ZIKV is a high priority. To validate commonly used antiviral drugs, we evaluated the effect of ribavirin, a drug used to treat hepatitis C with interferon-β (IFN-β), on ZIKV replication. In mammalian cells, we observed an inhibitory effect of ribavirin on ZIKV replication and ZIKV-induced cell death without cytotoxic effect. Furthermore, we found that STAT1-deficient mice, which lack type I IFN signaling, were highly sensitive to ZIKV infection and exhibited lethal outcome. Ribavirin abrogated viremia in ZIKV-infected STAT-1-deficient mice. These data suggest that the inhibition of viral RNA-dependent RNA polymerases may be effective for treatment of ZIKV infection. Our data provide a new insight into the mechanisms for inhibition of ZIKV replication and prevention of Zika fever. Ribavirin inhibits ZIKV replication in mammalian cells. Ribavirin prevents ZIKV-induced apoptosis and cell death. Ribavirin administration abrogates viremia in ZIKV-infected STAT1-deficient mice. Leading to a prolonged survival.
登录
查看更多内容
DOI:
10.1126/science.aaf5036
发表时间:
2016-04-15
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Faria NR;Azevedo RDSDS;Kraemer MUG;Souza R;Cunha MS;Hill SC;Thézé J;Bonsall MB;Bowden TA;Rissanen I;Rocco IM;Nogueira JS;Maeda AY;Vasami FGDS;Macedo FLL;Suzuki A;Rodrigues SG;Cruz ACR;Nunes BT;Medeiros DBA;Rodrigues DSG;Queiroz ALN;da Silva EVP;Henriques DF;da Rosa EST;de Oliveira CS;Martins LC;Vasconcelos HB;Casseb LMN;Simith DB;Messina JP;Abade L;Lourenço J;Alcantara LCJ;de Lima MM;Giovanetti M;Hay SI;de Oliveira RS;Lemos PDS;de Oliveira LF;de Lima CPS;da Silva SP;de Vasconcelos JM;Franco L;Cardoso JF;Vianez-Júnior JLDSG;Mir D;Bello G;Delatorre E;Khan K;Creatore M;Coelho GE;de Oliveira WK;Tesh R;Pybus OG;Nunes MRT;Vasconcelos PFC
通讯作者:
Vasconcelos PFC
DOI:
10.1056/nejmoa1602412
发表时间:
2016-12-15
期刊:
The New England journal of medicine
影响因子:
--
作者:
Brasil P;Pereira JP Jr;Moreira ME;Ribeiro Nogueira RM;Damasceno L;Wakimoto M;Rabello RS;Valderramos SG;Halai UA;Salles TS;Zin AA;Horovitz D;Daltro P;Boechat M;Raja Gabaglia C;Carvalho de Sequeira P;Pilotto JH;Medialdea-Carrera R;Cotrim da Cunha D;Abreu de Carvalho LM;Pone M;Machado Siqueira A;Calvet GA;Rodrigues Baião AE;Neves ES;Nassar de Carvalho PR;Hasue RH;Marschik PB;Einspieler C;Janzen C;Cherry JD;Bispo de Filippis AM;Nielsen-Saines K
通讯作者:
Nielsen-Saines K
影响因子:
8.8
作者:
Faye, Oumar;Faye, Ousmane;Sall, Amadou Alpha
通讯作者:
Sall, Amadou Alpha
影响因子:
4.8
作者:
Bougie, I;Bisaillon, M
通讯作者:
Bisaillon, M
影响因子:
5.2
作者:
Abdel-Hady, M.;Bansal, S.;Kelly, D. A.
通讯作者:
Kelly, D. A.